Healy James

DirectorCoherus BioSciences, Inc. (CHRS) · full profile →Form 4 · filed Sep 29, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7.3M
Net Open-Market Flow
-$7.3M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 29, 2021Sell(S)286K$16.12$4.6M0
Sep 28, 2021Sell(S)48K$17.17$830K286K
Sep 27, 2021Sell(S)100K$18.06$1.8M334K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-120896) within minutes of acceptance. Every field above traces to the original document. Verify it directly: